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reﬂexion
Human biodemography: Some challenges
and possibilities for aging research1
Kaare Christensen2
Abstract
This opinion report - in a series on the future of biodemography - focuses on promising
areas that I think will be valuable to develop in the future in order to get a better under-
standing of the determinants of the health and well-being of elderly people. I discuss two
major themes:
i) the beneﬁts of strengthening the ties between biodemography and medical-clinical
disciplines to better understand the link between functioning/diseases/vulnerability
and mortality,
ii) the male-female health-survival paradox (i.e., males report better health than fe-
males, but encounter higher mortality at all ages), and how this paradox may shed
light on fundamental aging processes.
1Opinion report solicited by Behavioral and Social Research (BSR) Program, National Institute on Aging in
response to recommendation from National Advisory Council on Aging (NACA), BRS Report, May 2004.
2Professor of Epidemiology, Director of the Danish Aging Research Center and the Danish Twin Registry,
University of Southern Denmark, 5000 Odense C, Denmark.
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1. Introduction
The purpose of this opinion report on the future of biodemography is to outline what I
consider to be promising areas of human biodemographic research that could lead to a
better understanding of the determinants of the health and well-being of elderly people.
2. Strengthening the ties between biodemography and medical-
clinical disciplines to better understand the link between
functioning/diseases/vulnerability and mortality
While biodemography has been exceptionally successful in establishing strong ties to and
collaboration with research areas as diverse as biology - especially evolutionary biology
- genetics, epidemiology, and public health (Ewbank 2004; Carey and Vaupel 2005) links
to the clinical sciences, in particular geriatrics, in the case of aging, and obstetrics, in the
case of fertility, could be further developed. Speciﬁcally, biodemographic aging research
traditionally uses mortality as outcome, but some studies also include the phenotypes that
are most central to elderly people, namely physical and cognitive functioning. This is
typically operationalized as ADL (activity of daily living) (Katz and Akpom 1976) and
cognitive tests (such as MMSE - Mini-Mental-State-Examination) (Folstein, Folstein and
McHugh 1975). These measures are known to be both valid and reliable and are by now
well integrated in many biodemographic studies.
2.1 Including diseases in human biodemographic research
Diseases are occasionally included in biodemographic analyses, often in the form of
cause-of-death or (number of) self-reported diseases. There is, however, considerable
concern about the validity of disease assessment made this way, and collaboration with
geriatrics is needed to improve this. Also conceptually, the terms “co-morbidity” and
“multi-morbidity” (the latter used more in Europe) are often used interchangeably, but
have different meanings. Multi-morbidity is the occurrence of several diseases in an in-
dividual, while co-morbidity denotes pre-existing diseases or conditions in reference to
an index disease (e.g. diabetes (co-morbidity) will increase the mortality risk due to hip
fracture (index disease)) (Yancik et al 2007).
The tradition of using number of diseases (often from a pre-existing list) as a measure
of multi-morbidity has the advantage of being conceptually simple and easy to handle in
statistical models, but it assumes that all the diseases on the list have the same impact and
it ignores interaction and common etiologies. This is sometimes addressed by weighting
and categorizations which on the other hand requires additional assumptions (Lash et al
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2007). When diseases are included in the analyses it is furthermore important to be clear
of the importance of the data source and its limitations (self-report, medical records, ad-
ministrative data) and whether the co-morbidity/multi-morbidity is a confounder, a mod-
iﬁer (interactor), or an outcome in the analyses. Work is in progress to deal with these
problems (Boyd et al 2007; Lash et al 2007), and the ﬁeld of biodemography could clearly
beneﬁt from this development.
2.2 Including frailty/vulnerability in human biodemographic research
A concept in geriatrics receiving increasing attention is frailty - not the statistical model
developed by Vaupel, Manton and Stallard (1979) - but a concept which is not equal to
either ADL’s or disease: a “clinical vulnerability” measure (Fried et al 2001). There is
no deﬁnition of frailty that is generally agreed upon, but most deﬁnitions operationalize
frailty through assessment of exhaustion, weakness, low and slow activity, and uninten-
tional weight loss (Walston et al 2006; Strandberg and Pitkälä 2007). There is still some
conceptual disagreement in frailty research: whether it is an intermediate factor between
morbidity and disability, and whether it is a single syndrome or range of phenotypes re-
lated to clinical traits associated with aging (Walston et al 2006). However, when disabil-
ities, diseases, and frailty are operationalized in ﬁeld studies there is a substantial overlap,
but also distinct features of the three measures of the health and functioning of the elderly.
These three measures are also clearly related to “allostatic load” (Seeman et al 2001) -
a concept developed initially as a measure of “accumulated damage”, but now moving
more towards a concept of physiological dysregulation.
A better understanding of these concepts and their operationalizations is needed and
several initiatives funded by WHO and NIA already address this need (Gruenewald et al
2006). It will require a close collaboration with geriatricians and physiologists to integrate
this new knowledge into the biodemographic framework. If better measures of the health
resources, functioning, and vulnerability of the elderly can be developed, this will provide
an important outcome to biodemography: not only will this hopefully lead to a better
understanding of the mechanisms behind age-related loss of health and functioning, but it
could also be a powerful tool in understanding mortality trajectories.
2.3 Other potentially productive research directions
A number of other promising research areas that could shed light on the link between
disability/morbidity/frailty and mortality could be:
² Development of speciﬁc disability/frailty/morbidity measures, their evolutionary
and theoretical background, their physiological plausibility, and their empirical as-
http://www.demographic-research.org 1577Christensen: Human biodemography: Some challenges and possibilities for aging research
sociation with mortality. The latter should take into account the statistical chal-
lenges of the individual level versus the population level analyses mentioned below.
² Evolutionary perspectives. Is the “end-stage disability and frailty”, which is the
focus of most human research, relevant in an evolutionary perspective or should
minor disabilities and frailty be considered? The justiﬁcation is that in nature, and
hence during evolution, such minor disabilities would be associated with very high
mortality.
² Animal models of disabilities/frailty will be an important concept to develop. In
particular, the use of animal models to study sex-differences in disability-mortality
associations, as mentioned below.
3. The male-female health-survival paradox
In the April 8, 2006 issue of the British Medical Journal, an editorial announced: Life
expectancy: Women now on top everywhere. During 2006, even in the poorest countries,
women could expect to outlive men (Barford et al 2006). However, there is a remarkable
discrepancy between the health and survival of men versus women: According to a recent
report on health differences in 21 European countries, men rated their health better than
women in all but one country, Finland, with signiﬁcant differences in 13 countries (Olsen
and Dahl 2007). An example: Grip strength is shown to predict disability, morbidity, and
mortality in both sexes but still the mean grip strength of 80-year-old men corresponds to
the mean grip strength of 45-year-old women (Frederiksen et al 2006). Generally men are
stronger, report fewer diseases, and have fewer limitations in the activities of daily living
at older ages. Nonetheless, female death rates are substantially lower than male rates for
all age groups. That is, in terms of mortality, women are healthier than men.
Interpretation of this apparent contradiction is complicated by several factors, and
a number of explanations have been proposed that are rooted in biological, social, and
psychological interpretations. Among the explanations for these sex differences in health,
the most commonly proposed are: biological risks, risks acquired through social roles
and behaviors, illness behavior, health reporting behavior, physicians’ diagnostic patterns,
and differential health care access, treatment, and use (Waldron 1985, Verbrugge 1985,
Preston 1976, Case and Paxson 2005).
3.1 Sex differences in morbidity
The issue of sex differences in morbidity is more complex than the pattern of sex differ-
ences in ADL and physical performance tests. The complexity is due to variations in def-
initions of diseases, diagnostic procedures and age-related changes in incidence rate for
many diseases. For example, coronary heart disease (CHD) incidence starts rising about
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10 years earlier in males than in females and is about twice as high in middle-aged men
compared to women of the same age (Castelli 1988, Wingard et al 1983, Wingard et al
1989, Heart Statistics 2004), but the male excess of CHD incidence and mortality declines
after sixty, and in the eighties the difference is small (Wingard et al 1989, Rich-Edwards
et al 1995, Jousilahti et al 1999). Further, the severity of diseases may also interfere with
female-male differences. Current literature reveals inconsistent patterns of disease sever-
ity among females and males. Thus, the excess of disease and disease severity in either
males or females will depend on the illness under investigation and the procedures used
to measure the severity. Studies generally show that women have a signiﬁcantly higher
mean number of reported symptoms for, and prevalence of, migraine and arthritis as well
as other musculoskeletal and autoimmune diseases (all low mortality risk diseases), while
males have an earlier and higher incidence of cardiovascular diseases (high mortality risk
diseases) (Macintyre et al 1996).
3.2 Biological and behavioral explanations
Among the most prominent biological explanations are the hormonal, autoimmune and
genetic explanations which suggest that biological factors unique for women can com-
pensate for their lesser muscle strength and higher prevalence of disability compared to
males. The observation that males have a rise in cardiovascular disease approximately
10 years before females combined with the known favorable effect of estrogen on serum
lipids and its protective effect on brain cells and consequent prevention of degenerative
processes (Austad 2006) has led to the hypothesis that estrogen is a central factor in the
paradox.
The “immunocompetence” hypothesis states that increased male mortality throughout
life may be caused in part by a greater susceptibility of males to infections (Owens 2002,
Crimmins and Finch 2004, 2006) although today mortality due to infectious diseases is
not a major cause of death in the Western world.
According to the X-chromosome hypothesis the lack of a second X chromosome in
the male is associated with increased mortality. Studies of peripheral blood cells from el-
derly monozygotic female twins show a strong tendency for the same cell line to become
predominant in two co-twins, which suggests that X-linked genetic factors inﬂuence hu-
man hematopoietic stem-cell kinetics and potentially organismal survival. The fact that
females have two cell lines with different potentials could be one of the reasons why
women live longer than men (Christensen et al 2000, Austad 2006).
The health-survival paradox is likely to be due to multiple causes including funda-
mental biological differences between the sexes such as genetic factors, immune system
response, hormones and disease patterns. Behavioral differences such as risk taking or
reluctance to seek and comply with medical treatment are also likely to play a role. An-
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other consideration is that part of the difference could be due to bias in surveys if males
are more reluctant than females to participate and/or accurately report in surveys if they
have disabilities or diseases.
3.3 Potentially productive research directions
² Important research questions that need more attention to shed light on the male-
female paradox of health and survival are:
² To what extent is the health-survival paradox due to the deﬁnition of health and how
health is measured (disabilities vs. diseases, self-reported vs. measured vs. health
care use)?
² To what extent is the health-survival paradox due to male reluctance to report dis-
eases and to seek medical treatment?
² To what extent is the health-survival paradox due to different transition rates from
an “unhealthy state” to either death or “a healthy state” for males and females? Do
“unhealthy” men have higher mortality rates and is the sex difference in transition
rates dependent on how “unhealthy” is deﬁned?
² To what extent is the health-survival paradox due to fundamental biological pro-
cesses which are constant across populations and can these processes be identiﬁed
in animal models?
4. Methodology and design developments
In this last section I will touch upon a methodological challenge as well as an opportunity
for a new research design option in aging research that takes advantage of changes in
contemporary family structures.
4.1 Individual versus population differences
A striking disconnect between the trajectories of individuals and populations is seen
among the oldest-old. When physical functioning is followed longitudinally in a co-
hort of the oldest-old, only a slight decline in the mean functioning of the entire cohort
is observed. The functioning for those individuals who have survived to 100, however,
has declined considerably from how they were functioning at age 92. The difference
in individual-level versus cohort-level aging is due to selection, whereby the frailest in-
dividuals die ﬁrst (Christensen et al. 2008). Furthermore, risk factors known to affect
lifespan earlier in life seem to lose importance later in life. Better methods for getting
insight into the underlying mechanisms taking the selection into account are warranted
to address the question of risk factors at the highest ages. This will probably come from
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the survival analysis ﬁeld, but there is also a need for development of better approaches
to the treatment of missing data in aging research. The longitudinal studies of aging
in biodemography needed for causal inference are challenged by drop-outs due to death
and “usual non-response” that is often associated with severe disease. Currently, the
techniques used are (multiple) imputations, inverse probability weighting, GEE (Gener-
alized Estimating Equations), EM Algorithms (Expectation-Maximization Algorithms),
and multilevel models assuming that the missing values are “missing at random” (con-
ditional on the last measurement)which in most cases is an assumption that is likely to
be violated (Raudenbush and Chan 1993, Dufouil et al 2004, Taylor 2004). Furthermore,
bio-demographic aging research meets special challenges because the number of drop-
outs due to death considerably exceeds what is usually seen in other studies.
4.2 Aging studies of half-siblings and full siblings
Studies of half-siblings, full siblings, and adopted siblings have been widely used in re-
productive research on adverse pregnancy outcome and early life health. In countries
with population registers it is possible, on a nationwide level, to identify individuals who
changed spouse or residence (or other environmental factors). This study design is par-
ticularly well suited for studying nature-nurture effects on reproductive outcomes and is
named the “computerized square dance study design” (like a traditional square dance,
modern life often involves more than one partner and one place) (Olsen, Schmidt and
Christensen 1997).
In its simplest form, it tests whether genetic factors are important for adverse preg-
nancy outcomes: a risk reduction is expected after change of partner. In its more elaborate
form, the design provides the opportunity to disentangle similarities due to common fam-
ily environment from genetic effects (Basso, Olsen and Christensen 1999) although it will
present analytical challenges such as different kin connections among half-sibs may have
implications for childhood environment and that this may differ between paternal and
maternal half-sibs.
Due to high divorce rates in many western countries from the 1960ies onwards the
number of middle-aged individuals with siblings, half-sibs and foster sibs will increase
dramatically in the coming years. The establishment of longitudinal aging studies of sib-
ships will provide important leverage to the ongoing studies of aging in relatives such
as twin and adoption studies. Sib-ships studies will increase the power to disentangle
the effect of genes and environment in aging and especially to shed light on the effect of
genes as well as early environment on the health and mortality trajectories at older ages.
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5. Conclusion
Biodemography has the potential to synthesize the ever increasing amount of biological
(in particular genetic) and medical data on large populations to help understand the de-
terminants of health and well-being among elderly people. It is important that biodemog-
raphy strengthens its ties with geriatrics and physiology to take advantage of the greater
understanding of disability, frailty, and diseases and how they affect the well-being and
survival of the elderly. The basis for the sex differences in health and survival is still
poorly understood, and much is likely to be learned by biodemographic studies of why,
around the globe, males have a shorter lifespan despite the fact that in nearly all countries
they report a better health status than women.
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